Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ratings

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

LipoScience Inc Lowers High End Of Prior FY 2013 Revenue Guidance

Tuesday, 5 Nov 2013 04:05pm EST 

LipoScience Inc announced that for fiscal 2013, it is narrowing its revenue guidance to between $52 million and $53 million. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $53 million for fiscal 2013. 

Company Quote

-0.01 -0.19%
11:08am EDT